LexaGene Holdings

About:

LexaGene Holdings is a molecular diagnostics company that develops a system for the detection of pathogens and other molecular markers.

Website: http://www.lexagene.com

Twitter/X: lexa_gene

Description:

LexaGene is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, food safety, and for use in open-access markets such as clinical research, agricultural testing, and biodefense. End-users simply need to collect a sample, load it onto the MiQLab™ system with a sample preparation cartridge, enter sample ID and press ‘go’. The MiQLab system delivers excellent sensitivity, specificity, and breadth of detection and can return results in quickly. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Total Funding Amount:

6.64M CAD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Beverly, Massachusetts, United States

Founded Date:

2016-10-12

Contact Email:

info(AT)lexagene.com

Founders:

Daryl Rebeck, Jack Regan

Number of Employees:

1-10

Last Funding Date:

2019-10-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai